[Home ] [Archive]   [ فارسی ]  
:: Main :: About us :: Current Issue :: Archive :: Search :: Submit :: Contact ::
:: Volume 15, Issue 2 (Summer 2018) ::
Sci J Iran Blood Transfus Organ 2018, 15(2): 113-119 Back to browse issues page
Epidemiological study of endocrine disorders in patients with B-Thalassemia major in Kurdistan province in 2013
B. Morad Visi, S. Azizi, A. Fathollah pour, Behzad Khalafi
Keywords: Key words: Blood Transfusion, Endocrine Disease, beta-Thalassemia, Epidemiology
Full-Text [PDF 397 kb]   (746 Downloads)     |   Abstract (HTML)  (3082 Views)
Type of Study: Research | Subject: Epidemiolgy & Statistical
Published: 2018/06/15
Full-Text:   (1487 Views)
  1. Hoffman R, Benz Jr EJ, Silberstein LE, Heslop H, Anastasi J, Weitz J. Hematology: Basic principles and practice. 6th ed. Philadelphia: Churchill Livingstone; 2013. p546-71.
  2. Orkin STNathan DG, Ginsburg D,  Thomas Look A,  Fisher DELux S.  Nathan and Oski's Hematology of Infancy and Childhood. 7th ed. Philadelphia: Saunders; 2008. p. 1050-3.
  3. Canatan D. The Thalassemia center of Antalya State Hospital: 15 years of experience (1994 to 2008). J Pediatr Hematol Oncol 2013; 35(1): 24-7.
  4. Kurtoglu AU, Kurtoglu E, Temizkan AK. Effect of iron overload on endocrinopathies in patients with beta-thalassaemia major and intermedia. Endokrynol Pol 2012; 63(4): 260-3.
  5. Adil A, Sobani ZA, Jabbar A, Adil SN, Awan S. Endocrine complications in patients of beta thalassemia major in a tertiary care hospital in Pakistan. J Pak Med Assoc 2012; 62(3): 307-10.
  6. Habeb AMAl-Hawsawi ZMMorsy MMAl-Harbi AMOsilan ASAl-Magamsi MS, et al. Endocrinopathies    in     beta - thalassemia     major.
Prevalence, risk factors, and age at diagnosis in Northwest Saudi Arabia. Saudi Med J 2013; 34(1): 67-73.
  1. Perera NJ, Lau NS, Mathews S, Waite C, Ho PJ, Caterson ID. Overview of endocrinopathies associated with β-thalassaemia major. Intern Med J 2010; 40(10): 689-96.
  2. Fung EB, Harmatz PR, Lee PD, Milet M, Bellevue R, Jeng MR, et al. Increased prevalence of iron-overload associated endocrinopathy in thalassaemia versus sickle-cell disease. Br J Haematol 2006; 135(4): 574-82.
  3. Kashanchi Langarodi M, Abdoirahim Poorheravi H. Prevalence of diabetes, hypothyroidism and hypoparathyroidism in thalassemia patients in Shahid Bahonar Hospital, Karaj.  Sci J Iran Blood Transfus Organ 2013; 9(4): 422-8. [Article in Farsi]
  4. Inati A, Noureldine MA, Mansour A, Abbas HA. Endocrine and bone complications in β-thalassemia intermedia: Current understanding and treatment. Biomed Res Int 2015; 2015: 813098.

Sci J Iran Blood Transfus Organ 2018; 15(2): 113-119
Original Article


Epidemiological study of endocrine disorders in patients with
B-Thalassemia major in Kurdistan province in 2013
Moradveisi V.1, Azizi S.2, Fathollahpour A.1, Khalafi B.2
1Besat Hospital, Kurdistan University of Medical Sciences, Sanandaj, Iran
2Kurdistan University of Medical Sciences, Sanandaj, Iran
Background and Objectives
Major beta-thalassemia is a hereditary hemoglobinopaty that is characterized by a genetic deficiency in the synthesis hemoglobin polypeptide chain. The aim is to determine endocrine disorders such as diabetes, hypothyroid, hypo-parathyroid, low growth hormone, hypogonadism and deranged glucose tolerance test and their relation with sexuality, age, ferritin measure and Desferal beginning age in Kurdistan province in 2013.
Materials and Methods
In this descriptive study, all patients with major thalassemia over 3 year of age with treatment record in Sanandaj Besat Hospital were enrolled. For all patients, tests of  GTT, LH, FSH, FSH.T3, T4, TSH, PTH, Ferritin were conducted. The demographic information together with the beginning age of Desferal use were added to the questionnaire. Data were then analyzed by T-test, Kscore, linear regression and logistic regression in STATA-11 software.
Out of 43 patients, 20 had hypogonadism, 17 had low growth hormone, 2 diabetes, 4 hypoparathyroid, 3 hypothyroid, and 4 deranged glucose tolerance test result. We also found a significant corrrelation between hypogonadism with age, ferritin measure and the beginning age of the Desferal use. The correlation between deranged glucose tolerance test with ferritin measure was significant. There were no significant correlations between other variables.
This study showed that the prevalence rate of endocrine disorder in patients with thalassemia being more than healthy people. Therefore, all patients with major beta thalassemia over 15 years of age should undergo considerable clinical and laboratory evaluation for endocrine gland.
Key words: Blood Transfusion , Endocrine Disease , beta-Thalassemia , Epidemiology
Received:  18 Feb 2018
Accepted: 18 Apr 2018

Correspondence: Khalafi B., MD. Member of Student Research Committee of Faculty of Kurdistan University of Medical Sciences.
P.O.Box: 66177-13446, Sanandaj, Iran. Tel: (+9887) 33664673; Fax: (+9887) 33664643

Send email to the article author

Add your comments about this article
Your username or Email:


XML   Persian Abstract   Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Morad Visi B, Azizi S, Fathollah pour A, Khalafi B. Epidemiological study of endocrine disorders in patients with B-Thalassemia major in Kurdistan province in 2013. Sci J Iran Blood Transfus Organ. 2018; 15 (2) :113-119
URL: http://bloodjournal.ir/article-1-1001-en.html

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 15, Issue 2 (Summer 2018) Back to browse issues page
فصلنامه پژوهشی خون Scientific Journal of Iran Blood Transfus Organ
The Scientific Journal of Iranian Blood Transfusion Organization - Copyright 2006 by IBTO
Persian site map - English site map - Created in 0.05 seconds with 31 queries by YEKTAWEB 4341